RecruitingPhase 2NCT05006079

Opioid/Benzodiazepine Polydrug Abuse: Aim 3

Opioid/Benzodiazepine Polydrug Abuse: Integrating Research on Mechanisms, Treatment and Policies - Study 3


Sponsor

Wayne State University

Enrollment

24 participants

Start Date

Mar 13, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, the investigators will measure affective, neurocognitive and behavioral outcomes related to chronic use of opioids and benzodiazepines (screening phase), and in response to the administration of the opioid morphine, the benzodiazepine alprazolam, morphine then alprazolam, alprazolam then morphine, morphine+alprazolam simultaneously, and placebo (laboratory pharmacology experiment). The latter will enable the investigators to assess the effects of an opioid alone, benzodiazepine alone, concurrent and simultaneous administration of opioid+benzodiazepine, relative to a placebo control.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how the combination of opioids and sedative drugs (like benzodiazepines or alcohol) affects the brain and behavior. Researchers are recruiting adults who have experience using both types of substances — even recreationally — to better understand the risks of combining these drugs. You may be eligible if: - You are between 18 and 65 years old - You have personal experience over the past 10 years using both opioids and sedatives (or opioids and alcohol, with alcohol used on at least 3 days in the past month) - You are in generally good health - You are not currently seeking treatment for substance use You may NOT be eligible if: - You have a severe psychiatric disorder (psychosis, bipolar disorder, or severe depression) - You have a severe substance use disorder for any substance - You have had a drug overdose or suicidal thoughts in the past year - You currently take methadone, buprenorphine, or naltrexone - You are pregnant, breastfeeding, or sexually active without medically approved birth control (if female) - You have significant neurological, cardiovascular, or pulmonary disease - Your BMI is above 38 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMorphine

immediate release oral 15mg dose

DRUGAlprazolam

oral 0.25mg dose

DRUGPlacebo

Lactose


Locations(1)

Tolan Park Medical Building

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05006079


Related Trials